Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage B-Cell Chronic Lymphocytic Leukemia

• Main Authors: Dariusz Wołowiec (Author), Jarosław Dybko (Author), Tomasz Wróbel (Author), Donata Urbaniak-Kujda (Author), Bożena Jaźwiec (Author), Beata Tomaszewska-Toporska (Author), Katarzyna Kapelko-Słowik (Author), Stanisław Potoczek (Author), Kazimierz Kuliczkowski (Author)
• Format: Book
• Published: Hindawi Limited, 2006-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Syndecan-1 (CD138) is a transmembrane heparin sulfate proteoglycan expressed on distinct stages of differentiation of B-lymphoid cells. Its prognostic value in B-cell chronic lymphocytic leukemia (B-CLL) has not been evaluated so far. The serum concentration of sCD138 and some angiogenesis-involved...